Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib adjunctive treatment for acute mania
IRCT20200306046708N1Phase 3Not yet recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2633
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar disorder (BD) comparing Celecoxib + sodium valproate with Placebo + sodium valproate (2 arms). Primary endpoints: Mania symptom improvement and mania. Planned start Dec 2633; status: not yet recruiting.
02
Drugs
celecoxib
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20200306046708N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200306046708N1.